Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
17.53
+0.08 (0.46%)
At close: Mar 4, 2026, 4:00 PM EST
17.52
-0.01 (-0.06%)
Pre-market: Mar 5, 2026, 8:11 AM EST
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Eton Pharmaceuticals stock have an average target of 31, with a low estimate of 26 and a high estimate of 37. The average target predicts an increase of 76.84% from the current stock price of 17.53.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $29 → $30 | Strong Buy | Maintains | $29 → $30 | +71.14% | Mar 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $37 | Strong Buy | Maintains | $35 → $37 | +111.07% | Mar 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $35 | Strong Buy | Maintains | $33 → $35 | +99.66% | May 29, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $24 → $26 | Strong Buy | Reiterates | $24 → $26 | +48.32% | May 16, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $26 → $28 | Strong Buy | Maintains | $26 → $28 | +59.73% | May 14, 2025 |
Financial Forecast
Revenue This Year
80.84M
from 39.01M
Increased by 107.23%
Revenue Next Year
104.87M
from 80.84M
Increased by 29.72%
EPS This Year
-0.11
from -0.15
EPS Next Year
0.92
from -0.11
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 83.9M | 111.4M | ||||
| Avg | 80.8M | 104.9M | ||||
| Low | 76.7M | 99.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 115.0% | 37.8% | ||||
| Avg | 107.2% | 29.7% | ||||
| Low | 96.7% | 22.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.08 | 1.23 | |
| Avg | -0.11 | 0.92 | |
| Low | -0.14 | 0.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.